Phase I/II Study of SY-1425 (Tamibarotene) in Combination With Azacitidine and Venetoclax for Patients With Chronic Myelomonocytic Leukemia
Clinical trial NCT06085638 · WITHDRAWN
Trial details
- NCT number
- NCT06085638
- Sponsor
- M.D. Anderson Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-14
- Primary completion
- 2023-10-20
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.